Aquapharm adds to team to facilitate commercialization of marine biotech products

Aquapharm has made two major appointments to help it move closer to commercializing its marine biotech assets.

Jon Williams joins Aquapharm as business development director with a remit to explore non-pharmaceutical markets for its products in areas such as personal care, food, nutrition and industrial chemistry.

Also signing up at the Oban-based firm is Dr Lloyd Payne who becomes research director.

Payne is being charged with delivering the completion of the world’s largest marine-derived compound library which the company hopes to unveil to the market next year.

Andrew Spragg, chief executive and founder of Aquapharm, said: “Because we have this growing portfolio, we need people with specific sector experience.

“Jon’s considerable experience in the commercialisation of natural products will be invaluable.This appointment will catalyse our efforts to establish sustainable, diversified sources of revenue and act to support the longer-term development of novel pharmaceutical candidates.

More info